← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Anidulafungin currently has availability issues reported in 2 European registers: Greece, Ireland.
Shortage ATC J02AX06 · also listed as: anidulafungin · data refreshed 13 September 2026
As of 13 September 2026, 2 of the 9 tracked registers list current availability issues for Anidulafungin, covering 2 affected product presentations. The longest-running open report was filed in Greece on 2026-05-04 and has now been open for about 4 months. Where agencies state a cause, delivery delays lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Anidulafungin is coded J02AX06 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Ecalta (anidulafungin) | 2024-07-01 | — | Candidiasis | register ↗ |
| 🇬🇷 Greece | Limited availability ANIDULAFUNGIN | 2026-05-04 | 2026-07-06 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της | register ↗ |
| 🇮🇪 Ireland | Shortage ECALTA 100 mg powder for concentrate for solution for infusion EU/1/07/4 | 2026-08-10 | 2026-08-17 | Manufacturing delay (Multiple countries) Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Anidulafungin in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇪 IE | ECALTA 100 mg powder for concentrate for solution for infusion EU/1/07 | Shortage | 2026-08-10 | 2026-08-17 | Manufacturing delay (Multiple countries) |
| 🇬🇷 GR | ANIDULAFUNGIN | Limited availability | 2026-05-04 | 2026-07-06 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇪🇺 EU | Ecalta (anidulafungin) | Resolved | 2024-07-01 | — | Candidiasis |
Yes. As of 13 September 2026, availability issues are reported in: Greece, Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Anidulafungin: EMA shortages catalogue (EU), EOF limited-availability list (Greece), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Anidulafungin — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/anidulafungin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Anidulafungin availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/anidulafungin/">Anidulafungin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>